EVA Pharma to open vaccine manufacturing facility in Cairo
The new facility will provide an important boost to vaccine capacity in Africa
The new facility will provide an important boost to vaccine capacity in Africa
Bioanalytical approach to accelerate development efforts in the identification of compounds that can treat chlorine or sulfur mustard injuries
It is the world’s first DNA-based Covid vaccine
The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23
The release of this batch will secure the supply for hospitals and cancer centres that are involved in the clinical trials managed by the company
Two leaders in science combine complementary best-in-class technologies for biologics manufacturing customers
Following the review of around 20 candidate vaccines by the external advisory group, MVC's vaccine was selected as one of two to be included in the global trial
Strengthens supply chain continuity with first manufacturing facility outside of the U.S.
Pluss Advanced Technologies (PLUSS), has led the growth of energy storage materials across applications. Their proprietary Phase Change Material has gained wide acceptance in the pharmaceutical, logistics and food industries. The varied demands of the industry during Covid-19 has brought its technology into focus. Samit Jain, MD, PLUSS in conversation with Thomas C Thottathil discusses trends and outlines his plans for the business
Subscribe To Our Newsletter & Stay Updated